Skip to content
Clinical Trials for Alzheimer's Disease

The Villages, Florida

Alzheimer's disease clinical trials in The Villages, FL

10 Alzheimer's disease studies are recruiting participants at sites in The Villages as of November 16, 2026, according to ClinicalTrials.gov. Clinical Trials for Alzheimer's Disease can help you understand your options and connect with a study team.

Call (888) 927-5895
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

The Villages at a glance

  • 10 studies are recruiting at a site in The Villages.
  • By phase: Phase 1 (1), Phase 1/2 (1), Phase 2 (3), Phase 3 (5).
  • By sponsor: industry (10).
  • Most recent update to one of these records: November 16, 2026.

Studies recruiting in The Villages

Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

    • Phase 3
    • Ages 50 to 90
    • All sexes
    Sponsor
    Hoffmann-La Roche
    Study site
    Charter Research - Lady Lake/The Villages
    Registry record
    NCT07177352 · updated
  2. A Study to Investigate the Safety and Effectiveness of SAR448851 in Participants With Early Alzheimer's Disease

    • Phase 2
    • Ages 55 to 85
    • All sexes
    Sponsor
    Sanofi
    Study site
    Charter Research - Lady Lake- Site Number : 8400004
    Registry record
    NCT07688213 · updated
  3. A Study of Trontinemab in Cognitively Unimpaired Individuals at Risk for Progression to Symptomatic Alzheimer's Disease

    • Phase 3
    • Ages 55 to 80
    • All sexes
    Sponsor
    Hoffmann-La Roche
    Study site
    Charter Research - Lady Lake/The Villages
    Registry record
    NCT07717411 · updated
  4. A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzheimer's Disease

    • Phase 1
    • Ages 50 to 85
    • All sexes
    Sponsor
    Eli Lilly and Company
    Study site
    Charter Research, LLC
    Registry record
    NCT06297590 · updated
  5. A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).

    • Phase 3
    • Ages 55 and older
    • All sexes
    Sponsor
    Eli Lilly and Company
    Study site
    Charter Research - The Villages
    Registry record
    NCT07602582 · updated
  6. A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

    • Phase 3
    • Ages 55 to 90
    • All sexes
    Sponsor
    Karuna Therapeutics, Inc., a Bristol Myers Squibb company
    Study site
    Charter Research
    Registry record
    NCT06585787 · updated
  7. A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease

    • Phase 3
    • Ages 60 to 85
    • All sexes
    Sponsor
    Bristol-Myers Squibb
    Study site
    Charter Research - Lady Lake
    Registry record
    NCT06976216 · updated
  8. A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)

    • Phase 2
    • Ages 50 to 85
    • All sexes
    Sponsor
    Merck Sharp & Dohme LLC
    Study site
    Charter Research - Lady Lake ( Site 1019)
    Registry record
    NCT07033494 · updated
  9. Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease

    • Phase 2
    • Ages 55 to 90
    • All sexes
    Sponsor
    Celgene
    Study site
    Charter Research - Lady Lake
    Registry record
    NCT06808984 · updated
  10. A Study to Assess the Effects of ACI-24.060 in Alzheimer's Disease and in Down Syndrome (ABATE Study)

    • Phase 1/2
    • Ages 35 to 85
    • All sexes
    Sponsor
    AC Immune SA
    Study site
    Charter Research, LLC
    Registry record
    NCT05462106 · updated

Source: ClinicalTrials.gov. Data processed . See every Alzheimer's disease study recruiting in The Villages, FL on ClinicalTrials.gov.

Ask about studies near The Villages

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

More locations in Florida

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

Clinical Trials for Alzheimer's Disease does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-5895

or send a short form

How should we reach you?

Call